|
|
||||||||
Research Communications |
a Departments of Biochemistry and Molecular Biology, College of Medicine, University of South FloridaUSA
b The James A. Haley Veterans Hospital, Tampa, Florida 33612, USA
Acute hyperglycemia may contribute to the progression of atherosclerosis by regulating protein kinase C (PKC) isozymes and by accelerating vascular smooth muscle cell (VSMC) proliferation. We investigated acute glucose regulation of PKCß gene expression in A10 cells, a rat aortic smooth muscle cell line. Western blot analysis showed that PKCßII protein levels decreased with high glucose (25 mM) compared to normal glucose (5.5 mM), whereas PKCßI levels were unaltered. PKCß mRNA levels were depleted by 6075% in hyperglycemic conditions. To elucidate whether high glucose regulated PKCß expression via the common promoter for PKCßI and PKCßII, deletion constructs of the PKCß promoter ligated to CAT as reporter gene were transfected into A10 cells. Construct D (-411 to +179CAT) showed quenching in high glucose (25 mM) and suggested the involvement of a carbohydrate response element in the 5' promoter region of the PKCß gene. In actinomycin D-treated A10 cells, a 60% decrease in PKCß mRNA with high glucose treatment indicated that posttranscriptional destabilization by glucose was also occurring. We have demonstrated that glucose-induced posttranscriptional destabilization of PKCßII message is mediated via a nuclease activity present in the cytosol. The specificity of glucose to posttranscriptionally destabilize PKCßII mRNA, but not the PKCßI mRNA, was confirmed in both A10 cells and primary cultures from human aorta.Patel, N. A., Chalfant, C. E., Yamamoto, M., Watson, J. E., Eichler, D. C., Cooper, D. R. Acute hyperglycemia regulates transcription and posttranscriptional stability of PKCßII mRNA in vascular smooth muscle cells. FASEB J. 13, 103113 (1999)
Key Words: A10 cells human AoSMC acute hyperglycemia posttranscriptional regulation glucose
This article has been cited by other articles:
![]() |
M. Campbell and E. R. Trimble Modification of PI3K- and MAPK-Dependent Chemotaxis in Aortic Vascular Smooth Muscle Cells by Protein Kinase C{beta}II Circ. Res., February 4, 2005; 96(2): 197 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Patel, H. S. Apostolatos, K. Mebert, C. E. Chalfant, J. E. Watson, T. S. Pillay, J. Sparks, and D. R. Cooper Insulin Regulates Protein Kinase C{beta}II Alternative Splicing in Multiple Target Tissues: Development of a Hormonally Responsive Heterologous Minigene Mol. Endocrinol., April 1, 2004; 18(4): 899 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Patel, D. C. Eichler, D. S. Chappell, P. A. Illingworth, C. E. Chalfant, M. Yamamoto, N. M. Dean, J. R. Wyatt, K. Mebert, J. E. Watson, et al. The Protein Kinase C beta II Exon Confers mRNA Instability in the Presence of High Glucose Concentrations J. Biol. Chem., January 3, 2003; 278(2): 1149 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Christopher, V. Velarde, D. Zhang, D. Mayfield, R. K. Mayfield, and A. A. Jaffa Regulation of B2-kinin receptors by glucose in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1537 - H1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, M. Acevedo-Duncan, C. E. Chalfant, N. A. Patel, J. E. Watson, and D. R. Cooper Acute glucose-induced downregulation of PKC-beta II accelerates cultured VSMC proliferation Am J Physiol Cell Physiol, September 1, 2000; 279(3): C587 - C595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guha, W. Bai, J. L. Nadler, and R. Natarajan Molecular Mechanisms of Tumor Necrosis Factor alpha Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways J. Biol. Chem., June 2, 2000; 275(23): 17728 - 17739. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Patel, C. E. Chalfant, J. E. Watson, J. R. Wyatt, N. M. Dean, D. C. Eichler, and D. R. Cooper Insulin Regulates Alternative Splicing of Protein Kinase C beta II through a Phosphatidylinositol 3-Kinase-dependent Pathway Involving the Nuclear Serine/Arginine-rich Splicing Factor, SRp40, in Skeletal Muscle Cells J. Biol. Chem., June 15, 2001; 276(25): 22648 - 22654. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |